Human leukocyte antigen class II alleles (DQB1 and DRB1) as predictors for response to interferon therapy in HCV genotype 4

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Shaker, Olfat ^a   Bassiony, Heba ^b   El Raziky, Maissa ^a   El Kamary, Samer S ^c   Esmat, Gamal ^a   El Ghor, Akmal M ^b   Mohamed, Mona M ^b  

^a CAIRO UNIVERSITY   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; ALPHA2B INTERFERON PLUS RIBAVIRIN; HLA DQB1 ANTIGEN; HLA DRB1 ANTIGEN; VIRUS RNA; ALPHA INTERFERON; HLA DQ ANTIGEN; HLA-DQB1 ANTIGEN; RIBAVIRIN;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HEPATITIS C; HUMAN; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT RESPONSE; ALLELE; GENETICS; HEPATITIS C VIRUS; MIDDLE AGED; PATHOGENICITY; TREATMENT OUTCOME;

HEPATITIS C VIRUS;

ADULT; ALLELES; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HLA-DQ BETA-CHAINS; HLA-DRB1 CHAINS; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; RIBAVIRIN; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84876590218     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/392746     Document Type: Article

References (52)

1. Deuffic-Burban S., Mohamed M. K., Larouze B., Carrat F., Valleron A. J., Expected increase in hepatitis C-related mortality in Egypt due to pre-2000 infections. Journal of Hepatology 2006 44 3 455 461 2-s2.0-32444432395 10.1016/j.jhep.2005.08.008 (Pubitemid 43227869)
2. Elkady A., Tanaka Y., Kurbanov F., Sugauchi F., Sugiyama M., Khan A., Sayed D., Moustafa G., Abdel-Hameed A. R., Mizokami M., Genetic variability of hepatitis C virus in south Egypt and its possible clinical implication. Journal of Medical Virology 2009 81 6 1015 1023 2-s2.0-66449104769 10.1002/jmv.21492
3. Rustgi V. K., The epidemiology of hepatitis C infection in the United States. Journal of Gastroenterology 2007 42 7 513 521 2-s2.0-34547576427 10.1007/s00535-007-2064-6 (Pubitemid 47190067)
4. El Makhzangy H., Esmat G., Said M., ElRaziky M., Shouman S., Refai R., Rekacewicz C., Gad R. R., Vignier N., Abdel-Hamid M., Zalata K., Bedossa P., Pol S., Fontanet A., Mohamed M. K., Response to pegylated interferon alfa-2a and ribavirin in chronic hepatitis C genotype 4. Journal of Medical Virology 2009 81 9 1576 1583 2-s2.0-68949098506 10.1002/jmv.21570
5. Bhatti Z., Berenson C. S., Adult systemic cat scratch disease associated with therapy for hepatitis C. BMC Infectious Diseases 2007 7, article 8 2-s2.0-33847795424 10.1186/1471-2334-7-8 (Pubitemid 46390783)
6. Harris H. E., Eldridge K. P., Harbour S., Alexander G., Teo C. G., Ramsay M. E., Alexander G., Gunson B., Heptonstall J., Hewitt P., Mieli-Vergani G., Nicholas H., Portmann B., Ramsay M., Robinson A., Does the clinical outcome of hepatitis C infection vary with the infecting hepatitis C virus type? Journal of Viral Hepatitis 2007 14 3 213 220 2-s2.0-33846969570 10.1111/j.1365-2893.2006. 00795.x
7. Dai C. Y., Chuang W. L., Hsieh M. Y., Huang J. F., Lin Y. Y., Chu P. Y., Hou N. J., Lin Z. Y., Chen S. C., Hsieh M. Y., Wang L. Y., Yu M. L., Human leukocyte antigen alleles and the response to pegylated interferon/ribavirin therapy in chronic hepatitis C patients. Antiviral Research 2010 85 2 396 402 2-s2.0-74449083238 10.1016/j.antiviral.2009.11.006
8. Villadangos J., Presentation of antigens by MHC class II molecules: getting the most out of them. Molecular Immunology 2001 38 329 346 10.1016/S0161-5890(01)00069-4 (Pubitemid 33001242)
9. Traherne J. A., Human MHC architecture and evolution: implications for disease association studies. International Journal of Immunogenetics 2008 35 3 179 192 2-s2.0-43549121020 10.1111/j.1744-313X.2008.00765.x (Pubitemid 351678693)
10. Shiina T., Hosomichi K., Inoko H., Kulski J. K., The HLA genomic loci map: expression, interaction, diversity and disease. Journal of Human Genetics 2009 54 1 15 39 2-s2.0-58849104457 10.1038/jhg.2008.5
11. Timm J., Li B., Daniels M. G., Bhattacharya T., Reyor L. L., Allgaier R., Kuntzen T., Fischer W., Nolan B. E., Duncan J., Zur Wiesch J. S., Kim A. Y., Frahm N., Brander C., Chung R. T., Lauer G. M., Korber B. T., Allen T. M., Human leukocyte antigen-associated sequence polymorphisms in hepatitis C virus reveal reproducible immune responses and constraints on viral evolution. Hepatology 2007 46 2 339 349 2-s2.0-34548304730 10.1002/hep.21702 (Pubitemid 47344768)
12. Hong X., Yu R. B., Sun N. X., Wang B., Xu Y. C., Wu G. L., Human leukocyte antigen class II DQB1*0301, DRB1*1101 alleles and spontaneous clearance of hepatitis C infection: a meta-analysis. World Journal of Gastroenterology 2005 11 46 7302 7307 2-s2.0-31344474524 (Pubitemid 43137680)
13. Isagulyants M. G., Ozeretskovskaya N. N., Role of a host in spontaneous recovery from viral hepatitis C: genetic predetermined factors. Voprosy Virusologii 2008 53 6 40 45 2-s2.0-58149271062
14. Yenigün A., Durupinar B., Decreased frequency of the HLA-DRB1*11 allele in patients with chronic hepatitis C virus infection. Journal of Virology 2002 76 4 1787 1789 2-s2.0-0036149939 10.1128/JVI.76.4.1787- 1789.2002 (Pubitemid 34094626)
15. Harris R. A., Sugimoto K., Kaplan D. E., Ikeda F., Kamoun M., Chang K. M., Human leukocyte antigen class II associations with hepatitis C virus clearance and virus-specific CD4 T cell response among Caucasians and African Americans. Hepatology 2008 48 1 70 79 2-s2.0-47149118872 10.1002/hep.22287 (Pubitemid 351975532)
16. Singh R., Kaul R., Kaul A., Khan K., A comparative review of HLA associates with hepatitis B and C viral infections across global populations. World Journal of Gastroenterology 2007 13 12 1770 1787 2-s2.0-34248207182 (Pubitemid 46706009)
17. Cangussu L., Teixeira R., Campos E., Rampim G., Mingoti S., Martins-Filho O., Gerbase-DeLima M., HLA class II alleles and chronic hepatitis C virus infection. Journal of Clinical Immunology 2011 74 3 282 287
18. Ali L., Mansoor A., Ahmad N., Siddiqi S., Mazhar K., Muazzam A. G., Qamar R., Khan K. M., Patient HLA-DRB1* and -DQB1* allele and haplotype association with hepatitis C virus persistence and clearance. Journal of General Virology 2010 91 8 1931 1938 2-s2.0-77955283850 10.1099/vir.0.018119-0
19. Jiao J., Wang J. B., Hepatitis C virus genotypes, HLA-DRB alleles and their response to interferon- α and ribavirin in patients with chronic hepatitis C. Hepatobiliary and Pancreatic Diseases International 2005 4 1 80 83 2-s2.0-14844314820 (Pubitemid 40347520)
20. de Rueda P. M., López-Nevot M. N., Sáenz-López P., Casado J., Martín-Casares A., Palomares P., Quiles R., Gila A., Romero-Gómez M., Pavón E. J., Mũoz J. A., Carazo Á., Sanz-Cameno P., Moreno-Otero R., Diago M., León J., Ruiz-Extremera Á., Salmerón J., Importance of host genetic factors HLA and IL28B as predictors of response to pegylated interferon and ribavirin. American Journal of Gastroenterology 2011 106 7 1246 1254 2-s2.0-79960035861 10.1038/ajg.2011.82
21. Hendy O., Abd Elmonean E., Allam M., Rady M., El Shazly H., Sabawy M., Tharwa E., Human leukocyte antigen class II, (HLA-II) alleles and interferon response in HCV chronically infected Egyptian patients. International Research Journal of Microbiology 2011 2 4 133 140
22. Bedossa P., Poynard T., An algorithm for the grading of activity in chronic hepatitis C. Hepatology 1996 24 2 289 293 2-s2.0-0029778988 10.1053/jhep.1996.v24.pm0008690394 (Pubitemid 26260021)
23. Roulot D., Bourcier V., Grando V., Deny P., Baazia Y., Fontaine H., Bailly F., Castera L., De Ledinghen V., Marcellin P., Poupon R., Bourlière M., Zarski J. P., Roudot-Thoraval F., Bresson-Hadni S., Gelu M., Pallier C., Gault E., Trimoulet P., Ripault M. P., Martinot-Peignoux M., Hézode C., Morand P., Trépo C., Benali S., Bronowicki J. P., Venard V., Gournay J., Sogni P., Pol S., Chaix M. L., Thabut D., Poynard T., Thibault V., Poujol-Robert A., Grangé J. D., Schneider V., Guyader D., Minjolle S., Vinel J. P., Sandres K., Epidemiological characteristics and response to peginterferon plus ribavirin treatment of hepatitis C virus genotype 4 infection. Journal of Viral Hepatitis 2007 14 7 460 467 2-s2.0-34250625319 10.1111/j.1365-2893.2006.00823.x (Pubitemid 46944469)
24. Gad R. R., Males S., El Makhzangy H., Shouman S., Hasan A., Attala M., El Hoseiny M., Zalata K., Abdel-Hamid M., Fontanet A., Mohamed M. K., Esmat G., Predictors of a sustained virological response in patients with genotype 4 chronic hepatitis C. Liver International 2008 28 8 1112 1119 2-s2.0-48949094213 10.1111/j.1478-3231.2008.01750.x
25. Bruno R., Sacchi P., Maiocchi L., Zocchetti C., Filice G., Host factors affecting the outcome of treatment of hepatitis C. Reviews in Gastroenterological Disorders 2004 4 supplement 1 S3 S7 2-s2.0-2942650861 (Pubitemid 38811491)
26. Morishima C., Polyak S. J., Ray R., Doherty M. C., Di Bisceglie A. M., Malet P. F., Bonkovsky H. L., Sullivan D. G., Greich D. R., Rothman A. L., Koziel M. J., Lindsay K. L., Hepatitis C virus-specific immune responses and quasi-species variability at baseline are associated with nonresponse to antiviral therapy during advanced hepatitis C. Journal of Infectious Diseases 2006 193 7 931 940 2-s2.0-33645363859 10.1086/500952
27. Hadziyannis S. J., Sette H., Morgan T. R., Balan V., Diago M., Marcellin P., Ramadori G., Bodenheimer H., Bernstein D., Rizzetto M., Zeuzem S., Pockros P. J., Lin A., Ackrill A. M., Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Annals of Internal Medicine 2004 140 5 346 355 2-s2.0-1542378867
28. Akuta N., Suzuki F., Sezaki H., Suzuki Y., Hosaka T., Someya T., Kobayashi M., Saitoh S., Watahiki S., Sato J., Kobayashi M., Arase Y., Ikeda K., Kumada H., Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype1b and high viral load. Journal of Medical Virology 2006 78 1 83 90 2-s2.0-28944436403 10.1002/jmv.20507 (Pubitemid 41783847)
29. Lombard Z., Brune A. E., Hoal E. G., Babb C., Van Helden P. D., Epplen J. T., Bornman L., HLA class II disease associations in Southern Africa. Tissue Antigens 2006 67 2 97 110 2-s2.0-33644901316 10.1111/j.1399-0039.2006.00530.x (Pubitemid 43383386)
30. de Re V., Caggiari L., Monti G., Libra M., Spina M., Dolcetti R., De Zorzi M., Racanelli V., Crovatto M., Toffoli G., HLA DR-DQ combination associated with the increased risk of developing human HCV positive non-Hodgkin's lymphoma is related to the type II mixed cryoglobulinemia. Tissue Antigens 2010 75 2 127 135 2-s2.0-73949089660 10.1111/j.1399-0039.2009.01414.x
31. Sim H., Wojcik J., Margulies M., Wade J. A., Heathcote J., Response to interferon therapy: influence of human leucocyte antigen alleles in patients with chronic hepatitis C. Journal of Viral Hepatitis 1998 5 4 249 253 2-s2.0-0031821318 10.1046/j.1365-2893.1998.00111.x (Pubitemid 28358228)
32. Yu M. L., Dai C. Y., Chen S. C., Chiu C. C., Lee L. P., Lin Z. Y., Hsieh M. Y., Wang L. Y., Chuang W. L., Chang W. Y., Human leukocyte antigen class I and II alleles and response to interferon- α treatment, in Taiwanese patients with chronic hepatitis C virus infection. Journal of Infectious Diseases 2003 188 1 62 65 2-s2.0-0037898228 10.1086/375554 (Pubitemid 36829743)
33. Itoh Y., Inoko H., Kulski J. K., Sasaki S., Meguro A., Takiyama N., Nishida T., Yuasa T., Ohno S., Mizuki N., Four-digit allele genotyping of the HLA-A and HLA-B genes in Japanese patients with Behcet's disease by a PCR-SSOP-Luminex method. Tissue Antigens 2006 67 5 390 394 2-s2.0-33646524700 10.1111/j.1399-0039.2006.00586.x
34. Heinemann F. M., HLA genotyping and antibody characterization using the Luminex multiplex technology. Transfusion Medicine and Hemotherapy 2009 36 4 273 278 2-s2.0-69549113042 10.1159/000228834
35. Hamed N. A., Hano A. F., Raouf H. A., Gamal M., Eissa M., Relationship between HLA-DRB1*0101, DRB1*0301 alleles and interleukin-12 in haemophilic patients and hepatitis C virus positive hepatocellular carcinoma patients. Egyptian Journal of Immunology 2003 10 1 17 26 2-s2.0-14844321959
36. Piekarska A., Woszczek G., Sidorkiewicz M., Kuydowicz J., HLA class II alleles and response to hepatitis C treatment with interferon alpha2b. Przeglad Epidemiologiczny 2002 56 1 123 128 2-s2.0-0036043288
37. Alric L., Izopet J., Fort M., Vinel J. P., Fontenelle P., Orfila C., Payen J. L., Sandres K., Desmorat H., Charlet J. P., Duffaut M., Abbal M., Study of the association between major histocompatibility complex class II genes and the response to interferon alpha in patients with chronic hepatitis C infection. Human Immunology 1999 60 6 516 523 2-s2.0-0033026354 10.1016/S0198-8859(99) 00021-X (Pubitemid 29296308)
38. Rhodes S. L., Erlich H., Im K. A., Wang J., Li J., Bugawan T., Jeffers L., Tong X., Su X., Rosen H. R., Yee L. J., Liang T. J., Yang H., Associations between the human MHC and sustained virologic response in the treatment of chronic hepatitis C virus infection. Genes and Immunity 2008 9 4 328 333 2-s2.0-44849095839 10.1038/gene.2008.21 (Pubitemid 351791488)
39. Vitte R. L., Fortier C., Richardet J. P., Grimbert S., Trinchet J. C., Beaugrand M., Lepage V., Raffoux C., HLA antigens in patients with chronic hepatitis C. Tissue Antigens 1995 45 5 356 361 2-s2.0-0029078188
40. Hüe S., Cacoub P., Renou C., Halfon P., Thibault V., Charlotte F., Picon M., Rifflet H., Piette J. C., Pol S., Caillat-Zucman S., Human leukocyte antigen class II alleles may contribute to the severity of hepatitis C virus-related liver disease. Journal of Infectious Diseases 2002 186 1 106 109 2-s2.0-0036642510 10.1086/341086 (Pubitemid 34666921)
41. Zavaglia C., Bortolon C., Ferrioli G., Rho A., Mondazzi L., Bottelli R., Ghessi A., Gelosa F., Iamoni G., Ideo G., HLA typing in chronic type B, D and C hepatitis. Journal of Hepatology 1996 24 6 658 665 2-s2.0-0030157661 10.1016/S0168-8278(96)80260-1 (Pubitemid 26226660)
42. Thursz M., Yallop R., Goldin R., Trepo C., Thomas H. C., Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The Lancet 1999 354 9196 2119 2124 2-s2.0-0033582107 (Pubitemid 30008896)
43. Cursino-Santos J., Donadi E., Martinelli A., Louzada-Junior P., Martinez-Rossi N., Evolution of hepatitis C virus infection under host factor influence in an ethnically complex population. Liver International 2007 27 1371 1378 (Pubitemid 350142251)
44. Corghi D., Gonçales N., Marques S., Gonçales J., Distribution of the human leukocyte antigen class II alleles in Brazilian patients with chronic hepatitis C virus infection. Brazilian Journal of Medical and Biological Research 2008 41 884 889
45. Knolle P. A., Kremp S., Höhler T., Krummenauer F., Schirmacher P., Gerken G., Viral and host factors in the prediction of response to interferen- α therapy in chronic hepatitis C after long-term follow-up. Journal of Viral Hepatitis 1998 5 6 399 406 2-s2.0-0031740154
46. Romero-Gómez M., González-Escribano M. F., Torres B., Barroso N., Montes-Cano M. A., Sánchez-Muñoz D., Núñez-Roldan A., Aguilar-Reina J., HLA class I B44 is associated with sustained response to interferon + ribavirin therapy in patients with chronic hepatitis C. American Journal of Gastroenterology 2003 98 7 1621 1626 2-s2.0-0037780509 (Pubitemid 36875358)
47. Kallinowski B., Scherer S., Mehrabi A., Theilmann L., Stremmel W., Clinical impact of HLA DR B1 genotypes in chronic hepatitis C virus infection. Transplantation Proceedings 1999 31 8 3346 3349 2-s2.0-0033253026
48. Vejbaesya S., Songsivilai S., Tanwandee T., Rachaibun S., Chantangpol R., Dharakul T., HLA association with hepatitis C virus infection. Human Immunology 2000 61 3 348 353 2-s2.0-0033993665 10.1016/S0198-8859(99)00131-7 (Pubitemid 30117805)
49. Alric L., Fort M., Izopet J., Vinel J. P., Charlet J., Selves J., Puel J., Pascal J. P., Duffaut M., Abbal M., Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection. Gastroenterology 1997 113 5 1675 1681 2-s2.0-0030831653 10.1053/gast.1997.v113. pm9352872 (Pubitemid 27461256)
50. El-Chennawi F. A., Auf F. A., Metwally S. S., Mosaad Y. M., El-Wahab M. A., Tawhid Z. E., HLA-class II alleles in Egyptian patients with hepatocellular carcinoma. Immunological Investigations 2008 37 7 661 674 2-s2.0-52949118091 10.1080/08820130802111605
51. Wawrzynowicz-Syczewska M., Underhill J. A., Clare M. A., Boron-Kaczmarska A., McFarlane I. G., Donaldson P. T., HLA class II genotypes associated with chronic hepatitis C virus infection and response to α -interferon treatment in Poland. Liver 2000 20 3 234 239 2-s2.0-0034111771 10.1034/j.1600-0676.2000.020003234.x (Pubitemid 30342722)
52. Yoon S. K., Han J. Y., Pyo C. W., Yang J. M., Jang J. W., Kim C. W., Chang U. I., Bae S. H., Choi J. Y., Chung K. W., Sun H. S., Choi H. B., Kim T. G., Association between human leukocytes antigen alleles and chronic hepatitis C virus infection in the Korean population. Liver International 2005 25 6 1122 1127 2-s2.0-28944443512 10.1111/j.1478-3231.2005.01105.x (Pubitemid 41782554)